The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Background: The prevalence of type 2 diabetes is on the increase worldwide, and it represents about 90% of adults who are diagnosed with diabetes. Overweight and obesity, lifestyle, genetic predisposition and gut microbiota dysbiosis have been implicated as possible risk factors in the development of type 2 diabetes. In particular, low intake of dietary fibre and consumption of foods high in fat and sugar, which are common in western lifestyle, have been reported to contribute to the depletion of specific bacterial taxa. Therefore, it is possible that intake of high dietary fibre may alter the environment in the gut and provide the needed substrate for microbial bloom. Aim: The current review is a systematic review and meta-analysis which evaluated the role of dietary fibre in modulating gut microbiota dysbiosis in patients with type 2 diabetes. Methods: This is a systematic review and meta-analysis of randomised controlled trials which relied on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework. Electronic searches were conducted using EBSCOHost with links to Health Sciences Research Databases, EMBASE and Google Scholar. The reference lists of articles were also searched for relevant studies. Searches were conducted from date of commencement of the database to 5 August 2020. The search strategy was based on the Population, Intervention, Comparator, Outcomes, Studies (PICOS) framework and involved the use of synonyms and medical subject headings (MesH). Search terms were combined with Boolean operators (OR/AND). Results: Nine studies which met the inclusion criteria were selected for the systematic review and meta-analysis, and four distinct areas were identified: the effect of dietary fibre on gut microbiota; the role of dietary fibre on short-chain fatty acids (SCFAs); glycaemic control; and adverse events. There was significant difference (p < 0.01) in the relative abundance of Bifidobacterium with a mean difference of 0.72 (95% CI, 0.56, 0.89) between the dietary fibre group compared with placebo. In relation to the meta-analysis for SCFAs, while there was significant difference (p = 0.02) between the dietary fibre group and placebo with a standardised mean difference of 0.5 (95% CI, 0.08, 0.91) regarding total SCFAs, the differences were not significant (p > 0.05) in relation to acetic acid, propionic acid and butyric acid. There was only significant improvement (p = 0.002) with respect to glycated haemoglobin with a mean difference of −0.18 (95% CI, −0.29, −0.06) between the dietary fibre group and placebo group. Differences between the two groups were not significant (p > 0.05) in relation to fasting blood glucose and homeostatic model assessment of insulin resistance (HOMA-IR). Furthermore, there were no significant differences between the two groups in subjects who reported adverse events. It is possible that the promotion of SCFA producers in greater diversity and abundance by dietary fibre in this review led to improvement in glycated haemoglobin, partly due to increased glucagon-like peptide-1 (GLP-1) production. In addition, Bifidobacterium lactis has been reported to increase glycogen synthesis, decrease expression of hepatic gluconeogenesis genes, improve translocation of glucose transport-4 and promote glucose uptake. It is also possible that the reduction in body weight of participants in the intervention group compared with control may have contributed to the observed improvement in glycated haemoglobin. Conclusion: This systematic review and meta-analysis have demonstrated that dietary fibre can significantly improve (p < 0.05) the relative abundance of Bifidobacterium, total SCFAs and glycated haemoglobin. However, dietary fibre did not appear to have significant effect (p > 0.05) on fasting blood glucose, HOMA-IR, acetic acid, propionic acid, butyric acid and adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A ran-domized double-blind trial in healthy adults demonstrated that pectin-containing soluble fiber improved postprandial glycemic control likely via increased GLP-1 secretion [129]”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [129]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Methley, A. M., Campbell, S., Chew-Graham, C., McNally, R., & Cheraghi-Sohi, S. (2014) · BMC Health Services Research · doi:10.1186/s12913-014-0579-0 · Cited by 2,706
The impact of dietary fiber on gut microbiota in host health and disease
Makki, K., Deehan, E. C., Walter, J., & Bäckhed, F. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.012 · Cited by 2,517 · cited 8×
“[7], dietary fibre can be subdivided into polysaccharides (NSP), resistant starch, and resistant oligosaccharides.”
BackgroundInfluentialGut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., Fu, H., Xue, X., Lu, C., Ma, J., et al. (2018) · Science · doi:10.1126/science.aao5774 · Cited by 2,304 · cited 3×
“[13], the acetate-producing Bifidobacterium pseudocatenulatum was one of the most significantly promoted SCFA producers, and the enhancement of these positive responders reduced the producers of compounds, such as indole and hydrogen sulphide, which could be metabolically detrimental.”
BackgroundResultSelf-citationWing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828
Role of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708
Meta-analysis of gut microbiome studies identifies disease-specific and shared responses
(2017) · doi:10.1038/s41467-017-01973-8 · Cited by 986 · cited 1×
“However, our current understanding of the exact relationships between the human gut microbiome and disease remains limited [12].”
BackgroundMcRorie, J. W., & McKeown, N. M. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2016.09.021 · Cited by 552
Mechanisms Underlying the Cholesterol-Lowering Properties of Soluble Dietary Fibre Polysaccharides
Gunness, P., & Gidley, M. J. (2010) · Food & Function · doi:10.1039/c0fo00080a · Cited by 527
Impact of Dietary Fiber Consumption on Insulin Resistance and the Prevention of Type 2 Diabetes
Weickert, M. O., & Pfeiffer, A. F. (2018) · The Journal of Nutrition · doi:10.1093/jn/nxx008 · Cited by 523
European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care
Durrer Schutz, D., Busetto, L., Dicker, D., Farpour-Lambert, N., Pryke, R., Toplak, H., Widmer, D., Yumuk, V., & Schutz, Y. (2019) · Obesity Facts · doi:10.1159/000496183 · Cited by 492
Meta-analyses of studies of the human microbiota
Lozupone, C. A., Stombaugh, J., Gonzalez, A., Ackermann, G., Wendel, D., Vázquez-Baeza, Y., Jansson, J. K., Gordon, J. I., & Knight, R. (2013) · Genome Research · doi:10.1101/gr.151803.112 · Cited by 424
The physiological roles of dietary fibre
Brownlee, I. A. (2011) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2009.11.013 · Cited by 417
Grundy, M. M.-L., Edwards, C. H., Mackie, A. R., Gidley, M. J., Butterworth, P. J., & Ellis, P. R. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516002610 · Cited by 395
Probiotics, prebiotics and amelioration of diseases
Tsai, Y.-L., Lin, T.-L., Chang, C.-J., Wu, T.-R., Lai, W.-F., Lu, C.-C., & Lai, H.-C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-018-0493-6 · Cited by 388 · cited 3×
“Poor dietary habits can lead to intestinal dysbiosis, such as alterations in the balance of the different bacterial phyla, including overgrowth of Proteobacteria and/or reduction in Bacteroidetes [16].”
BackgroundThe link between dietary fibre and human health
Kendall, C. W. C., Esfahani, A., & Jenkins, D. J. A. (2010) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2009.08.002 · Cited by 344
Healey, G., Murphy, R., Butts, C., Brough, L., Whelan, K., & Coad, J. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114517003440 · Cited by 267 · cited 2×
“There is evidence that diets play a significant role in modulating gut microbiota in terms of its composition and in the production of short-chain fatty acids (SCFAs) [11].”
BackgroundModulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet
Candela, M., Biagi, E., Soverini, M., Consolandi, C., Quercia, S., Severgnini, M., Peano, C., Turroni, S., Rampelli, S., Pozzilli, P., et al. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516001045 · Cited by 260
Anderson, J. W., Allgood, L. D., Turner, J., Oeltgen, P. R., & Daggy, B. P. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.4.466 · Cited by 247
The use of low-glycaemic index diets in diabetes control
Thomas, D. E., & Elliott, E. J. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510001534 · Cited by 225
Birkeland, E., Gharagozlian, S., Birkeland, K. I., Valeur, J., Måge, I., Rud, I., & Aas, A.-M. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02282-5 · Cited by 225 · cited 6×
“In ter s of the relationship bet een icrobiota and the SCF (acetic, propionic, butyric and valeric acid), a general trend was that acetic acid was positively related to operational taxonomic units (OTUs) that increased with the prebiotic fibre (Birkeland et al., 2020).”
BackgroundMethodResultInfluentialAnalysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals
Ahmad, A., Yang, W., Chen, G., Shafiq, M., Javed, S., Ali Zaidi, S. S., Shahid, R., Liu, C., & Bokhari, H. (2019) · PLOS ONE · doi:10.1371/journal.pone.0226372 · Cited by 191 · cited 1×
“In relation to bacterial taxonomy of the human gut microbiota, the four main phyla are Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria, and these are essential for the host metabolism and physiological regulation [2,6,15].”
BackgroundOjo, O., Ojo, O., Adebowale, F., & Wang, X.-H. (2018) · Nutrients · doi:10.3390/nu10030373 · Cited by 183
Self-citationEdwards, C. H., Grundy, M. M., Grassby, T., Vasilopoulou, D., Frost, G. S., Butterworth, P. J., Berry, S. E., Sanderson, J., & Ellis, P. R. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.106203 · Cited by 180
Medina-Vera, I., Sanchez-Tapia, M., Noriega-López, L., Granados-Portillo, O., Guevara-Cruz, M., Flores-López, A., Avila-Nava, A., Fernández, M. L., Tovar, A. R., & Torres, N. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.09.004 · Cited by 179 · cited 3×
“While three of these studies were conducted in Italy [26–28], one study each was carried out in Norway [29], Japan [30], Mexico [22], UK [23], Canada [31] and China [13].”
BackgroundResultLipid- and Glucose-Lowering Efficacy of Plantago Psyllium in Type II Diabetes
Rodríguez‐Morán, M., Guerrero‐Romero, F., & Lazcano-Burciaga, G. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(98)00003-8 · Cited by 157
Pedersen, C., Gallagher, E., Horton, F., Ellis, R. J., Ijaz, U. Z., Wu, H., Jaiyeola, E., Diribe, O., Duparc, T., Cani, P. D., et al. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516004086 · Cited by 117 · cited 1×
“While three of these studies were conducted in Italy [26–28], one study each was carried out in Norway [29], Japan [30], Mexico [22], UK [23], Canada [31] and China [13].”
ResultCereal fiber, fruit fiber, and type 2 diabetes: Explaining the paradox
Davison, K., & Temple, N. J. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.11.002 · Cited by 102
Houghton, D., Hardy, T., Stewart, C., Errington, L., Day, C. P., Trenell, M. I., & Avery, L. (2018) · Diabetologia · doi:10.1007/s00125-018-4632-0 · Cited by 94 · cited 1×
“Previous systematic reviews on gut microbiota and type 2 diabetes have focused on the broad subjects of dietary and/or lifestyle interventions [17] or probiotics and faecal microbial transplantation [6] and not primarily on dietary fibre.”
BackgroundRoshanravan, N., Alamdari, N. M., Jafarabadi, M. A., Mohammadi, A., Shabestari, B. R., Nasirzadeh, N., Asghari, S., Mansoori, B., Akbarzadeh, M., Ghavami, A., et al. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155101 · Cited by 94
From role of gut microbiota to microbial-based therapies in type 2-diabetes
Ebrahimzadeh Leylabadlo, H., Sanaie, S., Sadeghpour Heravi, F., Ahmadian, Z., & Ghotaslou, R. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104268 · Cited by 92
Roles for dietary fibre in the upper GI tract: The importance of viscosity
Mackie, A. R., Bajka, B. H., & Rigby, N. M. (2015) · Food Research International · doi:10.1016/j.foodres.2015.11.011 · Cited by 78
Gonai, M., Shigehisa, A., Kigawa, I., Kurasaki, K., Chonan, O., Matsuki, T., Yoshida, Y., Aida, M., Hamano, K., & Terauchi, Y. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0230 · Cited by 78 · cited 1×
“While three of these studies were conducted in Italy [26–28], one study each was carried out in Norway [29], Japan [30], Mexico [22], UK [23], Canada [31] and China [13].”
ResultPsyllium improves glycemic control in patients with type-2 diabetes mellitus
Feinglos, M. N., Gibb, R., Ramsey, D. L., Surwit, R. S., & McRorie, J. W. (2013) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2013.02.003 · Cited by 67
Woldeamlak, B., Yirdaw, K., & Biadgo, B. (2019) · The Korean Journal of Gastroenterology · doi:10.4166/kjg.2019.74.6.314 · Cited by 66 · cited 2×
“The prevalence of type 2 diabetes is on the increase globally, and it represents about 90% of adults who are diagnosed with diabetes [1,2].”
BackgroundFallucca, F., Porrata, C., Fallucca, S., & Pianesi, M. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2518 · Cited by 64
Soare, A., Khazrai, Y. M., Del Toro, R., Roncella, E., Fontana, L., Fallucca, S., Angeletti, S., Formisano, V., Capata, F., Ruiz, V., et al. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-39 · Cited by 41
Reimer, R. A., Wharton, S., Green, T., Manjoo, P., Ramay, H. R., Lyon, M. R., Gahler, R. J., & Wood, S. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02328-8 · Cited by 35 · cited 5×
“[31] found that the abundance of Lactobacillus spp.”
BackgroundResultInfluentialAn Overview of Diabetes and its Complications
Ojo, O. (2016) · Diabetes Research - Open Journal · doi:10.17140/droj-2-e005 · Cited by 28
Self-citationGut microbiota and Ma-Pi 2 macrobiotic diet in the treatment of type 2 diabetes
Fallucca, F., Fontana, L., Fallucca, S., & Pianesi, M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.403 · Cited by 22
Birkeland, E., Gharagozlian, S., Birkeland, K. I., Holm, O. K. S., Thorsby, P. M., & Aas, A. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.70 · Cited by 21
Soare, A., Toro, R. D., Khazrai, Y. M., Mauro, A. D., Fallucca, S., Angeletti, S., Skrami, E., Gesuita, R., Tuccinardi, D., Manfrini, S., et al. (2016) · Nutrition and Diabetes · doi:10.1038/nutd.2016.29 · Cited by 20
Lee, S.-E., Choi, Y., Jun, J. E., Lee, Y., Jin, S., Hur, K. Y., Ko, G. P., & Lee, M. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0090 · Cited by 20 · cited 2×
“The SCFAs are mainly acetic acid, propionic acid and butyric acid, and they also regulate the host metabolism and inflammation [14].”
Background
Research works printed but not linked: 1
- The Nordic Cochrane Centre (2014). Review Manager (RevMan) [Computer Program], The Nordic Cochrane Centre, The Cochrane Collaboration. Version 5.3.
Cited by
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota
Fusco, W., Lorenzo, M. B., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., Lener, E., Mele, M. C., Gasbarrini, A., Collado, M. C., et al. (2023) · Nutrients · doi:10.3390/nu15092211 · Cited by 1,243
Dietary Fiber Intake and Gut Microbiota in Human Health
Fu, J., Zheng, Y., Gao, Y., & Xu, W. (2022) · Microorganisms · doi:10.3390/microorganisms10122507 · Cited by 394
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 380
“The interventions enhanced glycated hemoglobin levels [394].”
Diabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
Szczuko, M., Kikut, J., Szczuko, U., Szydłowska, I., Nawrocka-Rutkowska, J., Ziętek, M., Verbanac, D., & Saso, L. (2021) · Nutrients · doi:10.3390/nu13072452 · Cited by 165
“The role of dietary fiber was demonstrated to modulate gut microbiota dysbiosis in patients with type 2 diabetes [48].”
Background
Metadata
- Authors
- Ojo, O., Feng, Q.-Q., Ojo, O. O., & Wang, X.-H.
- Affiliations
- South London and Maudsley NHS Foundation Trust (GB)
- The School of Nursing, Soochow University, Suzhou 215006, China
- Soochow University (CN)
- Corresponding author
- Ojo, Omorogieva
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-10-23
- Volume
- 12
- Issue
- 11
- Pages
- 3239
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7690692
- OpenAlex
- W3093727803
- Cited by
- 134
- References
- 47
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 30 · 2023: 25 · 2022: 22 · 2021: 15 · 2020: 2
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Greenwich Academic Literature Archive (University of Greenwich) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- dietary fiber, type 2 diabetes, gut dysbiosis, short-chain fatty acids, Bifidobacterium, glycemic control, HbA1c, fasting blood glucose, adverse events, probiotics, prebiotics, dietary intervention, gut microbiota modulation, acetic acid, propionic acid, butyrate, fecal microbiota transplantation
- MeSH terms
- Gastrointestinal Microbiome, Glycemic Control, Adult, Diabetes Mellitus, Type 2, Dietary Fiber, Fatty Acids, Volatile, Female, Glycated Hemoglobin, Humans, Male, Randomized Controlled Trials as Topic, Glucagon-Like Peptide 1, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.